Shishir K. Maithel

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

This commentary highlights the key recent advances made in the field of pancreatic cancer. Although there has yet to be a major breakthrough in clinical care for the majority of patients, significant strides have been made in understanding the complex biology of this malignancy and identifying new therapeutic targets.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Viraj A. Master

UNITED STATES

View details

Mark Yarchoan

Johns Hopkins University

UNITED STATES

View details

David A. Kooby

UNITED STATES

View details

Mihir Maheshkumar Shah

Assistant Professor

Emory University

UNITED STATES

View details

Yuan Liu

Research Associate Professor

Emory University

UNITED STATES

View details

Juan Sarmiento

Professor

Emory University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shishir K. Maithel

Research Interests

Explore related searches

Contact this professor

Articles (18)

Recurrence After Gallbladder Cancer Resection: Prognostic Impact of CA19‐9 and CEA Levels at Baseline and During Surveillance

Incidence and Prognostic Implications of Lymphovascular Invasion in Node‐Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group

Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors

Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma

Preoperative platelet count as an independent predictor of long‐term outcomes among patients undergoing resection for intrahepatic cholangiocarcinoma

Long‐term survivors after curative‐intent resection for intrahepatic cholangiocarcinoma

Immune checkpoint inhibitors in hepatocellular carcinoma: A review of current clinical trials

Early experience with robotic central pancreatectomy with patient‐reported outcomes and comparison with open central pancreatectomy

Top advances of the year: Pancreatic cancer

Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy

Impact of adjuvant therapy on outcomes after curative‐intent resection for distal cholangiocarcinoma

Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

Implications of leukocytosis following distal pancreatectomy splenectomy (DPS) and association with postoperative complications

Resection of retroperitoneal tumors with inferior vena cava involvement without caval reconstruction

Response to a letter to the editor regarding inferior vena cava ligation

Patient perspective: Financial toxicity is a barrier to clinical trials and personalized therapy in cholangiocarcinoma

Patient reported outcomes: Financial toxicity is a barrier to clinical trials and personalized therapy in cholangiocarcinoma

Surgical outcomes of gastro‐entero‐pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma

Collaborators (6)

Viraj A. Master

Mark Yarchoan

David A. Kooby

Mihir Maheshkumar Shah

Yuan Liu

Juan Sarmiento

Make your next move.